Brain Science and Psychosomatic Medicine

The effect of electroacupuncture on the SIRT3/FOXO3/SOD2 signaling pathway in the substantia nigra of mice with Parkinson′s disease

  • Ling QI ,
  • Chuan HE ,
  • Yao WANG ,
  • Xiaolei ZHANG ,
  • Jun. MA
Expand
  • *.College of Acupuncture?moxibustion and Orthopaedics,Hubei University of Chinese Medicine,Wuhan 430065,Hubei,China

Received date: 2025-07-10

  Online published: 2025-12-25

Abstract

Objective Mechanism study of electroacupuncture on improving motor coordination in Parkinson′s disease mice model based on silent mating type information regulation 2 homolog 3/forkhead box protein O3/superoxide dismutase 2(SIRT3/FOXO3/SOD2) pathway. Methods A total of 66 C57BL/6 mice were divided into a control group (Ctrl, n = 15) and a model-establishment group (n = 51) using a random number table. The PD mouse model with impaired coordination was established by intraperitoneal injection of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Forty-eight successfully MPTP-induced PD model mice were equally divided into four groups using a random number table: the model group (MPTP, n = 12), the EA group (EA, n = 12), the inhibitor group (3-TYP, n = 12), and the inhibitor + EA group (3-TYP + EA, n = 12).The Ctrl group was given an equal volume of normal saline. The MPTP group received intraperitoneal injection of MPTP (30 mg/kg) once a day for 7 consecutive days to establish the PD animal model.The EA group was given EA stimulation at the "Fengfu" (GV16) and "Taichong" (LR3) acupoints 2 hours after MPTP injection, once a day for 14 consecutive days.The 3-TYP group was given intraperitoneal injection of 3-TYP (10 mg/kg) 2 hours before MPTP injection. The 3-TYP + EA group received EA stimulation at the "Fengfu" (GV16) and "Taichong" (LR3) acupoints 2 hours after MPTP injection on the basis of the treatment for the 3-TYP group, once a day for 14 consecutive days. In addition, other mice not receiving EA were restrained for 15 minutes. The pole test and hanging test were used to evaluate the motor coordination of mice. Immunohistochemistry was employed to detect the expression of tyrosine hydroxylase (TH) in the midbrain substantia nigra of mice. Western blot was used to measure the protein levels of the SIRT3/FOXO3/SOD2 pathway in the midbrain substantia nigra. Flow cytometry was applied to detect changes in mitochondrial membrane potential (MMP) and reactive oxygen species (ROS) levels in the midbrain substantia nigra of mice. Results Compared with the Ctrl group, the MPTP group showed a significantly prolonged total time in the pole test (P < 0.01), a significantly decreased score in the hanging test (P < 0.01), a significantly reduced average optical density of TH in the midbrain substantia nigra (P < 0.01), a significant down-regulation of SIRT3, FOXO3, and SOD2 contents in the midbrain substantia nigra (P < 0.01), a significant decrease in MMP (P < 0.01), and a significant increase in ROS levels (P < 0.01).Compared with the MPTP group, the EA group exhibited a significantly shortened total time in the pole test (P < 0.01), a significantly increased score in the hanging test (P < 0.01), an increased average optical density of TH in the midbrain substantia nigra (P < 0.01), a significant up-regulation of SIRT3 and SOD2 expressions (P < 0.01), an increased FOXO3 content (P < 0.05), a significant increase in MMP (P < 0.01), and a significant decrease in ROS levels in the midbrain substantia nigra (P < 0.01).There were no significant differences in all the above indicators between the 3-TYP group and the MPTP group (P > 0.05). Compared with the EA group, the 3-TYP group had a prolonged total time in the pole test (P < 0.01), a significantly decreased score in the hanging test (P < 0.01), a reduced average optical density of TH in the midbrain substantia nigra (P < 0.01), a significant down-regulation of SIRT3 and SOD2 expressions (P < 0.01), a decreased FOXO3 content (P < 0.05), a significant decrease in MMP (P < 0.01), and a significant increase in ROS levels (P < 0.01).Compared with the 3-TYP group, the 3-TYP + EA group had increased protein expressions of SIRT3 (P < 0.05), while there were no significant differences in the other above-mentioned indicators (P > 0.05). Conclusions EA can activate the SIRT3/FOXO3/SOD2 signaling pathway, inhibit the excessive accumulation of ROS, and alleviate mitochondrial oxidative stress, thereby protecting TH in the midbrain substantia nigra and improving motor coordination in PD model mice. However, EA cannot completely reverse the effect of the SIRT3 inhibitor.

Cite this article

Ling QI , Chuan HE , Yao WANG , Xiaolei ZHANG , Jun. MA . The effect of electroacupuncture on the SIRT3/FOXO3/SOD2 signaling pathway in the substantia nigra of mice with Parkinson′s disease[J]. The Journal of Practical Medicine, 2025 , 41(24) : 3815 -3823 . DOI: 10.3969/j.issn.1006-5725.2025.24.004

References

[1] GU Y Y, ZHAO X R, ZHANG N, et al. Mitochondrial dysfunction as a therapeutic strategy for neurodegenerative diseases: Current insights and future directions[J]. Ageing Res Rev,2024,102:102577. doi:10.1016/j.arr.2024.102577
[2] DING X S, GAO L, HAN Z, et al. Ferroptosis in Parkinson′s disease: Molecular mechanisms and therapeutic potential[J]. Ageing Res Rev, 2023, 91: 102077. doi:10.1016/j.arr.2023.102077
[3] ZHOU Z D, TAN E K. Oxidized nicotinamide adenine dinucleotide-dependent mitochondrial deacetylase sirtuin-3 as a potential therapeutic target of Parkinson's disease[J]. Ageing Res Rev,2020,62:101107. doi:10.1016/j.arr.2020.101107
[4] PISSADAKI E K, BOLAM J P. The energy cost of action potential propagation in dopamine neurons: Clues to susceptibility in Parkinson's disease[J]. Front Comput Neurosci,2013,7:13. doi:10.3389/fncom.2013.00013
[5] XI Y, TAO K, WEN X, et al. SIRT3-Mediated Deacetylation of DRP1K711 Prevents Mitochondrial Dysfunction in Parkinson's Disease[J]. Adv Sci (Weinh),2025,e2411235. doi:10.1002/advs.202570126
[6] CHEN Y, ZHAO A, LI Y,et al. Roles of SIRT3 in cardiovascular and neurodegenerative diseases[J]. Ageing Res Rev,2025,104:102654. doi:10.1016/j.arr.2024.102654
[7] RANGARAJAN P, KARTHIKEYAN A, LU J, et al.Dheen ST. Sirtuin 3 regulates Foxo3a-mediated antioxidant pathway in microglia[J]. Neuroscience, 2015,311:398-414. doi:10.1016/j.neuroscience.2015.10.048
[8] WANG J, YUE H, DONG Y, et al. Effective compound combination of Bufei Yishen formula ameliorates PM2.5-induced COPD by inhibiting mitochondrial oxidative stress through SIRT3-mediated FOXO3 deacetylation[J]. Phytomedicine,2025,140:156568. doi:10.1016/j.phymed.2025.156568
[9] FABBRI M, FERREIRA J J, RASCOL O. COMT Inhibitors in the Management of Parkinson's Disease[J]. CNS Drugs,2022,36(3):261-282. doi:10.1007/s40263-021-00888-9
[10] 高崚,陈王璐,王照钦,等. 针灸对帕金森病小鼠外周血Th17/Treg平衡的调节作用[J]. 中华中医药杂志,2022,37(12):7033-7038.
[11] 李亚楠,汪瑶,张小蕾,等. 电针对帕金森病小鼠便秘症状的影响[J]. 北京中医药大学学报,2022,45(1):102-108.
[12] 汪瑶,王彦春,马骏. 电针对帕金森病大鼠中脑黑质Sirt3/NLRP3/GSDMD信号通路的影响[J]. 针刺研究,2024,49(4):384-390.
[13] 张小蕾,胡梦妮,荣臻,等. 电针对帕金森病小鼠Nrf2/NLRP3/Caspase-1通路介导的细胞焦亡的影响[J]. 针刺研究,2024,49(1):15-22.
[14] 李含章,李亚楠,郭磊,等. 电针对帕金森病小鼠肠道NEK7/NLRP3炎症信号通路的影响[J]. 北京中医药大学学报,2024,47(10):1466-1473.
[15] JEON H, RYU S, KIM D, et al. Acupuncture stimulation at GB34 restores MPTP-induced neurogenesis impairment in the subventricular zone of mice[J]. Evid Based Complement Alternat Med, 2017, 2017: 3971675. doi:10.1155/2017/3971675
[16] 中国针灸学会. 实验动物常用穴位名称与定位第3部分: 小鼠[J]. 针刺研究, 2021, 46(5): 445-446.
[17] LUO H, PENG C, XU X, et al. The Protective Effects of Mogroside V Against Neuronal Damages by Attenuating Mitochondrial Dysfunction via Upregulating Sirtuin3[J]. Mol Neurobiol,2022,59(4):2068-2084. doi:10.1007/s12035-021-02689-z
[18] ZHANG Q S, HENG Y, MOU Z, et al. Reassessment of subacute MPTP-treated mice as animal model of Parkinson′s disease[J]. Acta Pharmacol Sin, 2017, 38(10): 1317-1328. doi:10.1038/aps.2017.49
[19] 张家瑞,陆瑾,王玥,等. 针灸治疗帕金森病作用机制的研究进展[J]. 中医药导报,2025,31(6):150-153,174.
[20] NAMASHIRI A, ABBASADEH M, GHAZIZADEH A. The effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on the cognitive and motor functions in rodents: A systematic review and meta-analysis[J]. Neurosci Biobehav Rev,2022,140:104792. doi:10.1016/j.neubiorev.2022.104792
[21] HSU W T, CHEN Y H, YANG H B, et al. Electroacupuncture Improves Motor Symptoms of Parkinson's Disease and Promotes Neuronal Autophagy Activity in Mouse Brain[J]. Am J Chin Med,2020,48(7):1651-1669. doi:10.1142/s0192415x20500822
[22] 胡梦妮,张小蕾,荣臻,等. 电针对MPTP诱导帕金森病小鼠FoXO1/NLRP3通路介导神经炎症的影响[J]. 实用医学杂志,2024,40(11):1494-1499. doi:10.3969/j.issn.1006-5725.2024.11.005
[23] SONG L K, MA K L, YUAN Y H, et al. Targeted Overexpression of α-Synuclein by rAAV2/1 Vectors Induces Progressive Nigrostriatal Degeneration and Increases Vulnerability to MPTP in Mouse[J]. PLoS One, 2015, 10(6):e0131281. doi:10.1371/journal.pone.0131281
[24] BIOSA A, ARDUINI I, SORIANO M E, et al. Dopamine Oxidation Products as Mitochondrial Endotoxins, a Potential Molecular Mechanism for Preferential Neurodegeneration in Parkinson's Disease[J]. ACS Chem Neurosci, 2018,9(11):2849-2858. doi:10.1021/acschemneuro.8b00276
[25] 熊薇,柴星星,李莉莉. 虾青素对帕金森病黑质多巴胺能神经元保护作用机制的研究进展[J]. 生理科学进展,1-13.
[26] JIMENEZ-DELHADO A, ORTIZ G G, DELGADO-LARA D L, et al. Effect of Melatonin Administration on Mitochondrial Activity and Oxidative Stress Markers in Patients with Parkinson's Disease[J]. Oxid Med Cell Longev, 2021,2021:5577541. doi:10.1155/2021/5577541
[27] LA VITOLA P, SZEGO E M, PINTO-COSTA R, et al. Mitochondrial oxidant stress promotes α-synuclein aggregation and spreading in mice with mutated glucocerebrosidase[J]. NPJ Parkinsons Dis, 2024,10(1):233. doi:10.1038/s41531-024-00842-8
[28] ZOROVA L D, POPKOV V A, PLOTNIKOV E Y, et al. Mitochondrial membrane potential[J]. Anal Biochem, 2018, 552: 50-59. doi:10.1016/j.ab.2017.07.009
[29] GONCALVES A M, PEREIR-SANTOS A R, ESTEVES A R, et al. The Mitochondrial Ribosome: A World of Opportunities for Mitochondrial Dysfunction Toward Parkinson's Disease[J]. Antioxid Redox Signal,2021,34(8):694-711. doi:10.1089/ars.2019.7997
[30] PILLAI V B, SUNDARESAN N R, JEEVANANDAM V, et al. Mitochondrial SIRT3 and heart disease[J]. Cardiovasc Res,2010,88(2):250-256. doi:10.1093/cvr/cvq250
[31] PARK J H, BURGESS J D, FAROQI A H, et al. Alpha-synuclein-induced mitochondrial dysfunction is mediated via a sirtuin 3-dependent pathway[J]. Mol Neurodegener, 2020,15(1):5. doi:10.1186/s13024-019-0349-x
[32] ZHOU Y, ZHAO Q, ZHANG Y, et al. A new andrographolide derivative ADA targeting SIRT3-FOXO3a signaling mitigates cognitive impairment by activating mitophagy and inhibiting neuroinflammation in Apoe4 mice[J]. Phytomedicine,2024, 124: 155298. doi:10.1016/j.phymed.2023.155298
[33] ZHU X, MA E, GE Y, et al. Resveratrol protects against myocardial ischemic injury in obese mice via activating SIRT3/FOXO3a signaling pathway and restoring redox homeostasis[J]. Biomed Pharmacother,2024,174:116476. doi:10.1016/j.biopha.2024.116476
[34] 张贵君,王彦春,汪瑶,等. 电针调节帕金森病小鼠黑质脑区SIRT3/AMPK/PGC-1α通路的作用研究[J]. 中国中医基础医学杂志,2025,31(1):99-106.
Outlines

/